Every so often a medical advance comes along that rewrites the script for treating a disease or condition. After today’s announcements of impressive results of a new type of cholesterol-lowering drug, that scenario just might happen in the next few years. The new drugs, called PCSK9 inhibitors, are monoclonal antibodies. They target and inactivate a specific protein in the liver. Knocking out this protein, called proprotein convertase subtilisin kexin 9, dramatically reduces the amount of harmful LDL cholesterol circulating in the bloodstream. Lower LDL translates…

Read More »

I have just come back from a conference in New Orleans about the use of Hyperbaric Oxygen Therapy and its application in many medical conditions. This was sponsored by International Hyperbaric Medical Association at the 11th International Symposium For Hyperbaric Medicine and it was one of the best conferences I have been to— right up there with the first Low Carb, High Fat Conference masterminded by the brilliant Prof Tim Noakes in Capetown, South Africa, two years ago. These meetings are free of the pharmaceutical and food industry influences that…

Read More »